Work

Managing a High-Specific-Activity Iobenguane Therapy Clinic: From Operations to Reimbursement

Year: 2021

Type: editorial

Abstract: Metaiodobenzylguanidine (MIBG, iobenguane) is a guanethidine analog that targets the norepinephrine transporter and, when radiolabeled with the β-emitter 131I, has been used with varying protocols to treat neuroendocrine tumors, including pheochromocytoma/paraganglioma (PPGL), neuroblastoma, and

Source: Journal of Nuclear Medicine

DOI: 10.2967/jnumed.121.262306

Authors: Sophia R. O’Brien, Daniel A. Pryma

Institutions: Hospital of the University of Pennsylvania, University of Pennsylvania

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Actinium Pharmaceuticals, Progenics Pharmaceuticals, Siemens, Ipsen